©Author(s) (or their employer(s)) 2026.
World J Gastrointest Surg. Feb 27, 2026; 18(2): 114378
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.114378
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.114378
Table 3 Prognostic comparison between groups, n (%)
| Prognosis | Synchronous group (n = 56) | Sequential group (n = 50) | χ2/t | P value |
| PFS (months) | 7.09 ± 2.60 | 7.58 ± 2.27 | 1.028 | 0.306 |
| OS | ||||
| 3 months after treatment | 56 (100.00) | 49 (98.00) | 1.131 | 0.288 |
| 6 months after treatment | 56 (100.00) | 48 (96.00) | 2.283 | 0.131 |
| 12 months after treatment | 51 (91.07) | 45 (90.00) | 0.035 | 0.851 |
- Citation: Yu Y, Yuan W, Lei J, Zhao CB, Tao CG, Liu SH, Wang BL. Synchronous vs sequential combination of transarterial chemoembolization and microwave ablation for hepatocellular carcinoma: Efficacy and prognosis. World J Gastrointest Surg 2026; 18(2): 114378
- URL: https://www.wjgnet.com/1948-9366/full/v18/i2/114378.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i2.114378